Anders Björk

1.1k total citations
11 papers, 860 citations indexed

About

Anders Björk is a scholar working on Immunology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anders Björk has authored 11 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anders Björk's work include Immunotherapy and Immune Responses (3 papers), Cancer therapeutics and mechanisms (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Anders Björk is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer therapeutics and mechanisms (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Anders Björk collaborates with scholars based in Sweden, United States and Germany. Anders Björk's co-authors include Anders Olsson, Tomas Leanderson, Martin Stenström, Thomas Vogl, David Liberg, Johannes Roth, Per Björk, Fredrik Ivars, Роберто Пили and John T. Isaacs and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and PLoS Biology.

In The Last Decade

Anders Björk

11 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Björk Sweden	10	439	297	212	121	110	11	860
Randy B. Howard United States	18	293 0.7×	128 0.4×	95 0.4×	124 1.0×	45 0.4×	31	922
Patrick P. Koty United States	15	416 0.9×	141 0.5×	189 0.9×	144 1.2×	105 1.0×	29	930
Kathleen Clancy United States	9	617 1.4×	131 0.4×	48 0.2×	132 1.1×	81 0.7×	14	920
Tomoki Kawai Japan	14	238 0.5×	244 0.8×	79 0.4×	58 0.5×	63 0.6×	38	702
Christopher Fisher United States	18	485 1.1×	61 0.2×	108 0.5×	75 0.6×	64 0.6×	30	992
Kazushige Kiguchi Japan	21	484 1.1×	125 0.4×	84 0.4×	248 2.0×	157 1.4×	67	958
Louise K. Hosking United Kingdom	19	603 1.4×	88 0.3×	119 0.6×	380 3.1×	80 0.7×	34	1.3k
Ji Youn Han South Korea	12	735 1.7×	154 0.5×	159 0.8×	284 2.3×	241 2.2×	27	1.1k
Yoonsang Cho United States	10	589 1.3×	333 1.1×	37 0.2×	103 0.9×	50 0.5×	12	1.5k

Countries citing papers authored by Anders Björk

Since Specialization

Citations

This map shows the geographic impact of Anders Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Björk more than expected).

Fields of papers citing papers by Anders Björk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Björk. The network helps show where Anders Björk may publish in the future.

Co-authorship network of co-authors of Anders Björk

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Björk. A scholar is included among the top collaborators of Anders Björk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Björk. Anders Björk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Пили, Роберто, Michael Häggman, Walter M. Stadler, et al.. (2011). Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer. Journal of Clinical Oncology. 29(30). 4022–4028. 161 indexed citations

Olsson, Anders, Anders Björk, Johan Vallon‐Christersson, John T. Isaacs, & Tomas Leanderson. (2010). Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. Molecular Cancer. 9(1). 107–107. 75 indexed citations

Björk, Per, Anders Björk, Thomas Vogl, et al.. (2009). Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides. PLoS Biology. 7(4). e1000097–e1000097. 270 indexed citations

Wennerberg, Johan, et al.. (2007). Development of a Practical and Reliable Synthesis of Laquinimod. Organic Process Research & Development. 11(4). 674–680. 9 indexed citations

Isaacs, John T., Роберто Пили, David Z. Qian, et al.. (2006). Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. The Prostate. 66(16). 1768–1778. 73 indexed citations

Andersson, Gunnar, Tomas Fex, Gunnar Hedlund, et al.. (2004). Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure−Activity Relationship. Journal of Medicinal Chemistry. 47(8). 2075–2088. 131 indexed citations

Dahlén, Eva, Mikael Andersson, Kim Dawe, et al.. (2000). Inhibition of Autoimmune Disease by the Immunomodulator Linomide Correlates with the Ability to Activate Macrophages. Autoimmunity. 32(3). 199–211. 19 indexed citations

Andersson, Gunnar, et al.. (1996). FG5893: A Potential New Generation Anxiolytic/Antidepressant Drug with High Affinity for 5‐HT_1A and 5‐HT_2A Receptors. CNS Drug Reviews. 2(4). 363–383. 2 indexed citations

McMillen, Brian A., et al.. (1993). Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats. Pharmacology Biochemistry and Behavior. 46(1). 125–129. 36 indexed citations

10.

Axelsson, Rolf, Agneta Nilsson, Erik Christensson, & Anders Björk. (1991). Effects of amperozide in schizophrenia. Psychopharmacology. 104(3). 287–292. 51 indexed citations

11.

Björk, Anders. (1989). Is social stress in pigs a detrimental factor to health and growth that can be avoided by amperozide treatment?. Applied Animal Behaviour Science. 23(1-2). 39–47. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact